These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36124108)

  • 1. Preclinical Pharmacokinetics, Tissue Distribution and in vitro Metabolism of FHND6091, a Novel Oral Proteasome Inhibitor.
    Yang X; Liu A; Yang L; Wen T; Wang J; Shi J; Zhou H; Chen Z; Lei M; Zhu Y
    Drug Des Devel Ther; 2022; 16():3087-3107. PubMed ID: 36124108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.
    Deng G; Liu W; Ma C; Rong X; Zhang Y; Wang Y; Wu C; Cao N; Ding W; Guan H; Cheng X; Wang C
    J Ethnopharmacol; 2019 May; 236():288-301. PubMed ID: 30872168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nonclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of SPH3127, a Novel Direct Renin Inhibitor.
    Zhang L; Mao Y; Gao Z; Chen X; Li X; Liu Y; Xia G
    Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):15-26. PubMed ID: 31494843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry.
    Liu Y; Yao X; Song L; Liu H; Zhao Q; Jiang J; Ni G; Shi C; Ma X; Zhou H; Liu D; Hu P
    J Pharm Biomed Anal; 2018 Aug; 157():189-200. PubMed ID: 29803910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite identification, tissue distribution, excretion and preclinical pharmacokinetic studies of ET-26-HCl, a new analogue of etomidate.
    Yu L; Chen X; Zhang WS; Zheng L; Xu WW; Xu MY; Jiang XH; Wang L
    R Soc Open Sci; 2020 Feb; 7(2):191666. PubMed ID: 32257329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of an ultra-performance liquid chromatography method with tandem mass spectrometry to pharmacokinetics, tissue distribution and excretion in the study of DAT-230, a novel tubulin-binding agent candidate, in rats.
    Tang J; Zhang C; Sun J; Zhao L; Zhang W; Liu Z; Sun L; Chen X
    J Pharm Biomed Anal; 2015 Jun; 110():49-57. PubMed ID: 25800882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral absorption, distribution, metabolism, and excretion of icaritin in rats by Q-TOF and UHPLC-MS/MS.
    Zhang SQ; Zhang SZ
    Drug Test Anal; 2017 Oct; 9(10):1604-1610. PubMed ID: 28303675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]tofogliflozin after oral administration and concomitant intravenous microdose administration of [13C]tofogliflozin in humans.
    Schwab D; Portron A; Backholer Z; Lausecker B; Kawashima K
    Clin Pharmacokinet; 2013 Jun; 52(6):463-73. PubMed ID: 23494983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, tissue distribution and excretion of compound 6c, a novel DPP-4 inhibitor, following intragastric administration in rats by ultra-performance liquid chromatography-tandem mass spectrometry.
    Wang L; Li X; Kong Y; Wang F; Zhang Q; Lin C; Rong R
    Eur J Pharm Sci; 2022 Jun; 173():106162. PubMed ID: 35248731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer.
    Lei M; Feng H; Bai E; Zhou H; Wang J; Qin Y; Zhang H; Wang X; Liu Z; Hai O; Liu J; Zhu Y
    Org Biomol Chem; 2019 Jan; 17(3):683-691. PubMed ID: 30601533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites characterization of chamaechromone in vivo and in vitro by using ultra-performance liquid chromatography/Xevo G2 quadrupole time-of-flight tandem mass spectrometry.
    Lou Y; Zheng J; Wang B; Zhang X; Zhang X; Zeng S
    J Ethnopharmacol; 2014; 151(1):242-52. PubMed ID: 24189033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Pharmacokinetics and in vitro Metabolism of FHND5071, a Novel Selective RET Kinase Inhibitor.
    Han Y; Wen T; Wang J; Shi J; Zhu Y
    Eur J Drug Metab Pharmacokinet; 2023 Sep; 48(5):595-614. PubMed ID: 37528327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile and metabolite identification of yuanhuapine, a bioactive component in Daphne genkwa by ultra-high performance liquid chromatography coupled with tandem mass spectrometry.
    Chen Y; Guo J; Tang Y; Wu L; Tao W; Qian Y; Duan JA
    J Pharm Biomed Anal; 2015 Aug; 112():60-9. PubMed ID: 25956226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical pharmacokinetics and ADME characterization of a novel anticancer chalcone, cardamonin.
    Jaiswal S; Shukla M; Sharma A; Rangaraj N; Vaghasiya K; Malik MY; Lal J
    Drug Test Anal; 2017 Aug; 9(8):1124-1136. PubMed ID: 27794181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacokinetics and in vitro metabolism of BMS-605339: a novel HCV NS3 protease inhibitor.
    Jenkins S; Scola P; McPhee F; Knipe J; Gesenberg C; Sinz M; Arora V; Pilcher G; Santone K
    J Pharm Sci; 2014 Jun; 103(6):1891-902. PubMed ID: 24700293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and metabolic profiling studies of sennoside B by UPLC-MS/MS and UPLC-Q-TOF-MS.
    Wu H; Feng F; Jiang X; Hu B; Qiu J; Wang C; Xiang Z
    J Pharm Biomed Anal; 2020 Feb; 179():112938. PubMed ID: 31816471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of TPN729 metabolites in humans using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Zhu Y; Li L; Deng P; Chen X; Zhong D
    J Pharm Biomed Anal; 2016 Jan; 117():217-26. PubMed ID: 26366939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.